ERBB2 and neoplasm: Indeed, ER, PR, and HER-2 IHC analysis provides an intrinsic classification of tumours identifying, among others, luminal B-like (HER-2+) and HER-2+ (non-luminal) tumours, both characterized by HER-2 receptor overexpression [5].